
News|Articles|November 24, 2025
Rethinking Clinical Trial Data in the Era of Decentralization
Author(s)Seriant
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
The Future Relationship Between AI and Field Reps
3
Eli Lilly to Acquire Merida Biosciences for $2.8 Billion
4
Pharma Has More Data Than Ever, This Doesn’t Mean It Has Better Intelligence
5
